<- Go Home
DrugMax Inc.
As of November 12, 2004, DrugMax, Inc. was acquired by FamilyMeds Group, Inc., in a reverse merger transaction. FamilyMeds Group, Inc. continued as the surviving company and continued the name of DrugMax, Inc. DrugMax, Inc. distributes pharmaceuticals, over-the-counter products, health and beauty care products, nutritional supplements, and related products in the United States and Puerto Rico. These products are distributed primarily to independent pharmacies in the United States, as well as to small and medium-sized pharmacy chains, alternative care facilities, and other wholesalers. DrugMax is headquartered in Clearwater, Florida.
Market Cap
N/A
Volume
2.3K
Cash and Equivalents
$345.9K
EBITDA
-$6.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.1M
Profit Margin
2.33%
52 Week High
$60.00
52 Week Low
$17.50
Dividend
N/A
Price / Book Value
26.75
Price / Earnings
-34.37
Price / Tangible Book Value
-206.31
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$6.2M
Return on Equity
58.26%
Return on Assets
-8.13
Cash and Short Term Investments
$345.9K
Debt
$12.2M
Equity
$12.2M
Revenue
$175.8M
Unlevered FCF
$8.3M
Sector
Distributors
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium